---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-025173"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T05:16:52.082087+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics Q1 revenue $81.9M (+44% YoY); raises FY2024-25 guidance

## Summary
- GAAP net income $17.8M vs net loss of $6.8M in prior year; adjusted EBITDA $26.4M, a 970% increase.
- Gross margin improved to 48% from 29% YoY; working capital $223.3M, cash $45.3M.
- FY2024 revenue guidance raised to >$355M (prior >$330M); net income >$85M (prior >$65M).
- FY2025 revenue guidance raised to >$410M; adjusted EBITDA >$160M, up from >$140M.

## SEC filing metadata
- accession: 0001140361-24-025173
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/0001140361-24-025173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/ef20028782_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-025173
- JSON: https://secwatch.observer/filing/0001140361-24-025173.json
- Plain text: https://secwatch.observer/filing/0001140361-24-025173.txt

## Key facts
- Earnings Releases
  ADMA BIOLOGICS, INC. reported three months ended March 31, 2024 results: revenue $81.9 Million, net income $17.8 Million. Guidance raised.
  - Period: three months ended March 31, 2024
  - Revenue: $81.9 Million
  - Net income: $17.8 Million
  - Guidance: raised
  - Result: reported results
  source text: ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update 1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/0001140361-24-025173-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.